1. Home
  2. DYAI vs XTIA Comparison

DYAI vs XTIA Comparison

Compare DYAI & XTIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • XTIA
  • Stock Information
  • Founded
  • DYAI 1979
  • XTIA 1999
  • Country
  • DYAI United States
  • XTIA United States
  • Employees
  • DYAI N/A
  • XTIA N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • XTIA
  • Sector
  • DYAI Health Care
  • XTIA
  • Exchange
  • DYAI Nasdaq
  • XTIA NYSE
  • Market Cap
  • DYAI 28.3M
  • XTIA 27.8M
  • IPO Year
  • DYAI 2004
  • XTIA N/A
  • Fundamental
  • Price
  • DYAI $1.01
  • XTIA $2.16
  • Analyst Decision
  • DYAI Strong Buy
  • XTIA
  • Analyst Count
  • DYAI 1
  • XTIA 0
  • Target Price
  • DYAI $6.00
  • XTIA N/A
  • AVG Volume (30 Days)
  • DYAI 58.3K
  • XTIA 2.9M
  • Earning Date
  • DYAI 08-12-2025
  • XTIA 08-13-2025
  • Dividend Yield
  • DYAI N/A
  • XTIA N/A
  • EPS Growth
  • DYAI N/A
  • XTIA N/A
  • EPS
  • DYAI N/A
  • XTIA N/A
  • Revenue
  • DYAI $3,554,344.00
  • XTIA $3,466,000.00
  • Revenue This Year
  • DYAI $22.56
  • XTIA $59.74
  • Revenue Next Year
  • DYAI $30.95
  • XTIA N/A
  • P/E Ratio
  • DYAI N/A
  • XTIA N/A
  • Revenue Growth
  • DYAI 57.59
  • XTIA 1475.45
  • 52 Week Low
  • DYAI $0.91
  • XTIA $0.96
  • 52 Week High
  • DYAI $2.20
  • XTIA $83.90
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 55.41
  • XTIA 49.70
  • Support Level
  • DYAI $0.91
  • XTIA $1.91
  • Resistance Level
  • DYAI $1.03
  • XTIA $2.47
  • Average True Range (ATR)
  • DYAI 0.05
  • XTIA 0.18
  • MACD
  • DYAI 0.01
  • XTIA 0.03
  • Stochastic Oscillator
  • DYAI 83.00
  • XTIA 63.53

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About XTIA XTI AEROSPACE

XTI Aerospace Inc is an aircraft development company. It also provides real-time location systems (RTLS) for the industrial sector. The company is developing a vertical takeoff and landing (VTOL) airplane that is designed to take off and land like a helicopter and cruise like a fixed-wing business airplane. Its initial configuration, the TriFan 600 airplane, will be one of the first civilian fixed-wing VTOL airplane that offers the speed and comfort of a business airplane and the range and versatility of VTOL for a wide range of customer applications, including private aviation for business and high net worth individuals, emergency medical services, and regional charter air travel. The company operates in two reportable segments: Industrial IoT and Commercial Aviation.

Share on Social Networks: